ibandronate vs ranitidine
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of ibandronate and ranitidine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
7.3 H2 Blockers In healthy volunteers, co-administration with ranitidine resulted in a 20% increased bioavailability of ibandronate, which was not considered to be clinically relevant (see CLINICAL PHARMACOLOGY [12.3] ) . 7.3 H2 Blockers In healthy volunteers, co-administration with ranitidine resulted in a 20% increased bioavailability of ibandronate, which was not considered to be clinically relevant (see CLINICAL PHARMACOLOGY [12.3] ) .
Boniva
Zantac
Ibandronate (Boniva) is a medicine that helps treat and prevent bone loss in women after menopause. It makes bones stronger and less likely to break.
Ranitidine (Zantac) helps reduce stomach acid. It can relieve heartburn and sour stomach.
Ibandronate is used to treat and prevent osteoporosis in women after menopause. Osteoporosis is a condition that makes bones weak and more likely to break. This medicine helps to increase bone strength and reduce the chance of fractures, especially in the spine.
This medicine treats heartburn caused by acid indigestion and sour stomach. You can also take it to prevent heartburn. It can prevent heartburn caused by eating or drinking certain foods and drinks.
Ibandronate belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone. This helps to increase bone density and reduce the risk of fractures.
Ranitidine is an H2 receptor antagonist. It works by blocking histamine. Blocking histamine reduces the amount of acid your stomach makes.
- • Back pain
- • Upset stomach
- • Pain in arms or legs
- • Diarrhea
- • Headache
- • Headache
- Arthralgia 243
- Diarrhoea 230
- Nausea 219
- Femur Fracture 216
- Headache 198
- Breast Cancer 24,853
- Prostate Cancer 22,252
- Colorectal Cancer 17,674
- Bladder Cancer 16,746
- Renal Cancer 16,278
This medicine can cause problems with your esophagus. To help prevent this, follow the directions carefully and stay upright for at least 60 minutes after taking it. Rarely, serious bone, joint, or muscle pain can occur. Tell your doctor if you have new pain in your thigh or groin. Osteonecrosis of the jaw (bone damage in the jaw) has been reported.
No specific warnings noted.
Ibandronate is not for use in women who can get pregnant. It is not known if this medicine will harm an unborn baby. Talk to your doctor if you are breastfeeding.
No pregnancy information available.
Also Compare, Nearby Drugs
Compare ibandronate with
Compare ranitidine with
How to Read This ibandronate vs ranitidine Comparison
ibandronate is classified in the Bisphosphonate drug class, while ranitidine sits within the H2 Receptor Antagonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, ibandronate has 1,106 submissions while ranitidine has 97,803. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to ranitidine increases the amount of ibandronate that is absorbed into your body.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for ibandronate or ranitidine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.